Error: Could not add to watchlist. X
+ Watchlist

Sarepta Therapeutics Inc

AB3A:GR
Frankfurt
30.78
EUR
0.03
0.09%
As of 10:13 AM EDT 6/26/2017
Open
31.02
Day Range
30.78 - 31.03
Volume
0
Previous Close
30.81
52Wk Range
15.00 - 56.41
1 Yr Return
84.58%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
31.02
Day Range
30.78 - 31.03
Volume
0
Previous Close
30.81
52Wk Range
15.00 - 56.41
1 Yr Return
84.58%
YTD Return
18.45%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
1.691
Shares Outstanding (m)
54.955
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.
Address
215 First Street
Suite 415
Cambridge, MA 02142
United States
Phone
1-617-274-4000
  • Edward M Kaye
    President/CEO
  • Sandesh Mahatme "Sandy"
    Exec VP/CFO/Chief Business Ofcr
  • Catherine Stehman-Breen
    Senior VP/Chief Med OFC
  • David Tyronne Howton Jr "Ty"
    Senior VP/Secretary/Gen Cnsl
  • Alexander Cumbo "Bo"
    Senior VP:Global Commercial
Show More